Lupin said on Monday that it has divested the US commercial women’s health specialty business to Evofem Biosciences for an undisclosed sum. This divestment is another step in aligning its US specialty business with their strategic plan to build their specialty business in therapeutic areas where they have building blocks of synergy, the company said. […]